SAN DIEGO, Oct. 25 — Accelrys and GlaxoSmithKline announced on Thursday that they have been in collaboration to produce a so-called “Hits and Leads Chemically Aware Spreadsheet” to enable GSK scientists to access, analyze, and visualize vast amounts of chemical and biological data stored in GSK’s R&D databases.
The technology is based on Accelrys’s Accord Grid Control, a tool for displaying multiple structures and reactions, as well as other data, in a grid format. The Grid Control was used as the basis of the data query and visualization tools and was interfaced to tools developed by GSK for uniting their databases.
Slava Budin-Jones, program manager at GSK said in a statement that Accelrys responded quickly to GSK’s request to work on site to jointly develop the initial prototype. Jeremy Potter, product manager for developer tools at Accelrys, said that the Accord Grid Control gives developers the ability to handle groups of structures and data with flexibility within one component.
Accelrys is a wholly-owned subsidiary of Pharmacopeia.